- BIOBUSINESS BRIEFS
- Correction 14 January 2020
Breast cancer drug approvals by the US FDA from 1949 to 2018
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature Reviews Drug Discovery 19, 11 (2020)
doi: https://doi.org/10.1038/d41573-019-00201-w
Acknowledgements
The authors thank A. Mollet at the European Center for Pharmaceutical Medicine, University of Basel, Switzerland, for her support.
Updates & Corrections
-
Correction 14 January 2020: The author affiliations in the pdf were incorrect. These have now been corrected in the online pdf.
Supplementary Information
Competing Interests
C.P.L. is employed by HBM Partners, which invests in emerging biotech companies.